drugset / Trial / NCT04522830

A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

NCT04522830 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Clinical trial to compare sublingual low does thimerosal in adults that have symptoms of SARS-CoV-2 Infection against placebo to show a difference in physical characteristics and viral levels.

Timeline

Start
2020-07-30
Primary completion
2021-02-28
Completion
2021-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Thimerosal Small molecule — Other

Indications